In September 2020, R-Zero engaged an independent clinical testing lab, to validate the efficacy of its flagship UV-C disinfection system, Arc, against human coronavirus, feline calicivirus (FCV), MRSA and E. coli carriers. R-Zero
selected microorganisms endemic to the environments Arc will be used in, ensuring partners understand Arc’s
efficacy against the pathogens most important to them.
Check out the Study Report Here.